Gene site-directed mutation method based on seamless cloning, and applications thereof
A gene site-directed mutation and seamless cloning technology, applied in the field of genetic engineering, can solve the problems that the mutation efficiency cannot reach 100%, the construction efficiency of mutant plasmids is low, and the operation is cumbersome, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] Example 1. An application example 1 of a gene site-directed mutation method based on seamless cloning technology
[0046] 1. Construction of the MEK1(Q56P)-pCold I recombinant plasmid in which the 56th glutamine residue of the MEK1 protein is mutated to proline
[0047] MEK1 is a dual-specificity protein kinase in the STE7 kinase family. Activated by phosphorylation modification by Raf, Mos and Cot kinases, MEK1 with kinase activity will make the threonine-glutamic acid-tyrosine motif in the activation loop of ERK1 and ERK2 protein domains. Threonine and tyrosine Acid residues are phosphorylated. MEK1 is an essential component of the MAP kinase signaling pathway, which is involved in various cellular biological processes, such as cell proliferation, cell differentiation, transcriptional regulation and development. According to literature reports, mutating the 56th glutamine residue of MEK1 protein to proline can constitutively activate MEK1 protein, so that it has kin...
Embodiment 2
[0089] Example 2. Application example 2 of a gene site-directed mutation method based on seamless cloning technology
[0090] EH-IscS is a chimeric cysteine desulfurase, which is obtained by fusing the N-terminal domain (amino acids 1-263) of Escherichia coli cysteine desulfurase IscS protein with human cysteine desulfurization The C-terminal domain (316-457 amino acids) of the enzyme NFS1 protein is constructed. Compared with NFS1, EH-IscS has enhanced protein stability and possesses cysteine desulfurase activity without accessory proteins.
[0091] The EH-IscS-pCold-SUMOa plasmid was provided by the Institute of Enzyme Engineering and Medical Diagnosis, Wenzhou Medical University.
[0092] 1. Construction of the EH-IscS(K206A)-pCold-SUMOa recombinant plasmid in which the 206th lysine of the EH-IscS protein is mutated to alanine
[0093] 1.1 Amplify the target plasmid fragment
[0094] 1.1.1 The PCR reaction system and conditions are as follows:
[0095] (1) Ampli...
Embodiment 3
[0122] Example 3. A gene site-directed mutagenesis kit based on seamless cloning technology
[0123] 1. A gene site-directed mutagenesis kit instruction manual based on seamless cloning technology
[0124] 1.1 Introduction to the kit
[0125] This gene site-directed mutagenesis kit uses two pairs of primers to amplify the target gene, two of which contain mutation site bases, and is suitable for site-directed mutagenesis of plasmids larger than 5kb. It overcomes the defect of uncertain success rate and fidelity of a pair of primers to amplify plasmids above 5kb when using ordinary high-fidelity enzymes; the amplified product adopts seamless cloning technology to construct a circular plasmid containing mutation sites, and the positive clone rate is greater than 90% %; Dpn I digestion, degradation of methylated non-mutant plasmid templates in vitro, and degradation of methylated non-mutant plasmid templates in DMT competent cells in vivo, so as to ensure that the positive clone...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com